Global Gene Synthesis Market Research and Forecast Report 2023- 2028 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved
About IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the c ompan y’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Highlight and Description According to the latest report by IMARC Group, titled "Gene Synthesis Market: Global Industry Trends, Share, Size, Grow th, Opportunity and Forecast 2023-2028," the global gene synthesis market size reached US$ 1.74 Billion in 2022. Gene synthesis refers to the laboratory method used to create a deoxyribonucleic acid (DNA) sequence . It involves the artificial construction of a specific sequence of nucleotides as compared to the extraction of naturally occurring DNA. It allows for exact control over the sequence, which enables researchers to create genes without any unwanted mutations . It is commonly used to study gene f unction, produce proteins, or engineer organisms with new capabilities . Request for a PDF sample of this report: https://www.imarcgroup.com/gene -synthesis-market/requestsample
Report Description Global Gene Synthesis Market Trends: The increasing preference for personalized medicines and new generation drugs and formulations on account of the surging prevalence of chronic and lifestyle disorders, such as cancer, diabetes, and A l zh e im e r ’ s, represents one of the major factors driving the need for gene synthesis around the world. Moreover, the rising geriatric population, which is susceptible to such ailments, is augmenting the market growth. In addition, the growing number of clinical trials by pharmaceutical companies and extensive improvements in medical infrastructure and diagnostic technologies are inf luencing the market positively. Apart from this, gene synthesis finds application in the agricultural sector to enable the development of crops with desired traits like drought resistance or enhanced nutritional value. This, coupled with the increasing farming activities and rising adoption of organic f arming practices, is strengthening the growth of the market. Looking forw ard, the market value is projected to reach US$ 4.82 Billion by 2028, expanding at a CAGR of 17.10% during 2023-2028. View Report TOC, Figures and Tables: h t t p s://www.im a r c g ro u p.c om/ g e n e-s y n t h e si s-m a r k e t
Report Segmentation Met hod Insights: • S olid-Ph a s e Synth es i s • C h ip-Ba s e d Synth es i s • PC R-Ba sed E n zyme Sy nth e s i s Ser vices Insights: • Antib o d y DNA Synth esi s • Vira l DNA Synth esi s • O th ers Application Ins ights: • Gen e a n d C ell T h era py Develo p me n t • Va c c in e Develop m e nt • Disea s e Dia gn o s i s • O th ers
Report Segmentation End Us e Ins ights : • Biotec h n o l og y a n d Ph a r ma c eu t ic a l C omp a n ie s • Aca d emic a n d Gover n m en t Resea rc h In stitu te s • C ontra c t Resea rc h O rga n izatio n s Regional Ins ights : • Nor th Amer ica • E u rop e • Asia-Pa c i fi c • Latin Amer ica • Mid d le Ea st a n d Afr ica
Competitive Landscape with Key Players • ATUM • B o ster B io logical Techno logy • Euro f ins Geno mics • Genew iz Inc. (Azenta Life S ciences) • Genscript B io tech Co rp. • Integrated DN A Techno logies Inc. • Merck KGaA • OriGene Techno logies Inc. • Pro Mab B io technologies Inc. • Pro teo Genix Inc • Thermo Fisher Scientific Inc. • Tw ist B io science
Key Questions Answered in the Report How has the global gene synthesis market performed so far, and how will it perform in the coming years? What are the drivers, restraints, and opportunities in the global gene synthesis market? What is the impact of each driver, restraint, and opportunity on the global gene synthesis market? What are the key regional markets? Which countries represent the most attractive gene synthesis market? What is the breakup of the market based on the method? Which is the most attractive method in the gene synthesis market? What is the breakup of the market based on the services?
Key Questions Answered in the Report Which are the most attractive services in the gene synthesis market? What is the breakup of the market based on the application? Which is the most attractive application in the gene synthesis market? What is the breakup of the market based on the end use? Which is the most attractive end use in the gene synthesis market? What is the competitive structure of the global gene synthesis market? Who are the key players/companies in the global gene synthesis market?
Table of Contents 1 Pr e fac e 2 Sc ope a nd M e t hodology 2 . 1 O bj ective s o f t h e St u d y 2 . 2 St ak eh o lde rs 2 . 3 Da t a So u r c es 2 . 3.1 Pr imary So u r c e s 2 . 3.2 Se c o n dary So u r c e s 2 . 4 Ma r k et Es t im atio n 2 . 4.1 Bo ttom -Up Ap p r o a ch 2 . 4.2 T o p-Do wn Ap p r o a ch 2 . 5 Fo r eca sting Me t h o d o log y 3 Ex e c utive Sum m ary 4 Global G e ne Synt he s i s M a r k et - I nt roduction 4 . 1 O vervie w 4 . 2 Ma r k et Dyn a m ic s 4 . 3 I n du stry T r e n ds 4 . 4 Co m petitive I n t ellig en ce 5 Global G e ne Synt he s i s M a r k et La nds c a pe 5 . 1 His t oric al a n d Cu r r e nt Ma r k et T r e n ds ( 2 0 1 7 -20 22 ) 5 . 2 Ma r k et Fo r e c a st ( 2 0 2 3 -20 28) 6 G l obal G e ne Synt he s i s M a r ke t - Br e a k up by M e t hod 6. 1 Solid-Phase Synt hesi s 6 . 1 . 1 O ve r vie w 6 . 1 . 2 His t o ric al a n d Cu r r e nt Ma r k et T r e n ds ( 2 0 1 7 -20 22 ) 6 . 1 . 3 Ma r k et Se g m enta tion 6 . 1 . 4 Ma r k et Fo r e c a st ( 2 0 2 3 -20 28 ) 6 . 2 Chi p-Ba s ed Synt he s i s 6 . 2 . 1 O ve r vie w 6 . 2 . 2 His t o ric al a n d Cu r r e nt Ma r k et T r e n ds ( 2 0 1 7 -20 22 ) 6 . 2 . 3 Ma r k et Se g m enta tion 6. 2. 4 Mar k et For ec ast ( 2023 -2028)
Table of Contents 6 . 3 PCR- Ba s ed Enz ym e Synt he s i s 6 . 3 . 1 O ve r vie w 6 . 3 . 2 His t o ric al a n d Cu r r e nt Ma r k et T r e n ds ( 2 0 1 7 -20 22 ) 6 . 3 . 3 Ma r k et Se g m enta tion 6 . 3 . 4 Ma r k et Fo r e c a st ( 2 0 2 3 -20 28 ) 6 . 4 At t r a c tive I nve s tme nt Pr opos ition by M e t hod 7 G l obal G e ne Synt he s i s M a r ke t - Br e a k up by Se r vi c es 7 . 1 Ant i body DNA Synt he s i s 7 . 1 . 1 O ve r vie w 7 . 1 . 2 His t o ric al a n d Cu r r e nt Ma r k et T r e n ds ( 2 0 1 7 -20 22 ) 7 . 1 . 3 Ma r k et Se g m enta tion 7 . 1 . 4 Ma r k et Fo r e c a st ( 2 0 2 3 -20 28 ) 7 . 2 Vi r al DNA Synt he s i s 7 . 2 . 1 O ve r vie w 7 . 2 . 2 His t o ric al a n d Cu r r e nt Ma r k et T r e n ds ( 2 0 1 7 -20 22 ) 7 . 2 . 3 Ma r k et Se g m enta tion 7 . 2 . 4 Ma r k et Fo r e c a st ( 2 0 2 3 -20 28 ) 7 . 3 O t hers 7 . 3 . 1 O ve r vie w 7 . 3 . 2 His t o ric al a n d Cu r r e nt Ma r k et T r e n ds ( 2 0 1 7 -20 22 ) 7 . 4 At t r a c t ive I nve s t ment Pr opos ition by Se r vi c e s 8 G l obal G ene Synt hesi s M ar ket - Br eakup by Appl i c a t ion 8 . 1 G e ne a nd Ce l l The r a py De ve l opme nt 8 . 1 . 1 O ve r vie w 8 . 1 . 2 His t o ric al a n d Cu r r e nt Ma r k et T r e n ds ( 2 0 1 7 -20 22 ) 8 . 1 . 3 Ma r k et Se g m enta tion 8 . 1 . 4 Ma r k et Fo r e c a st ( 2 0 2 3 -20 28 ) For m or e i nf ormation, vi si t: h t t p s : / / w w w . i m a r c g r o u p . c o m / g e n e -s y n t h e s i s-m a r k e t / t o c
Disclaimer © 2023 IMARC All Rights Reserved This Publication and all it’ s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies .
Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]